Spectrum Planning & Advisory Services Inc. Intellia Therapeutics, Inc. Transaction History

Spectrum Planning & Advisory Services Inc.

$101 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	SELL	$53.92 - $71.7 $8,842 - $11,758	-164 Reduced 3.51%	4,503 $252,000
Q2 2022 Jul 15, 2022	SELL	$38.49 - $76.21 $80,559 - $159,507	-2,093 Reduced 30.96%	4,667 $242,000
Q3 2021 Oct 13, 2021	SELL	$132.37 - $176.78 $19,193 - $25,633	-145 Reduced 2.1%	6,760 $907,000
Q2 2021 Jul 19, 2021	SELL	$60.88 - $161.91 $707,182 - $1.88 Million	-11,616 Reduced 62.72%	6,905 $1.12 Million
Q1 2021 Apr 27, 2021	BUY	$46.59 - $83.68 $9,318 - $16,736	200 Added 1.09%	18,521 $1.49 Million
Q4 2020 Feb 02, 2021	BUY	$18.83 - $63.53 $344,984 - $1.16 Million	18,321 New	18,321 $997,000

Others Institutions Holding NTLA

# of Institutions

313

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$150 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$118 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$117 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$62.9 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$60.5 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $929M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spectrum Planning & Advisory Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spectrum Planning & Advisory Services Inc. with notifications on news.

Account